The Inhibitory activity of Tobramycin and Liposomal-Tobramycin-N-Acetylcysteine formulations Against Uropathogenic Escherichia coli (UPEC) Biofilms

• R Alarfaj,
• S Aljihani,
• M Alzayer,
• S Al Johani,
• H Balkhy,
• A Yassin,
• M Omer,
• M AlKhulaifi,
• M Alghoribi,
• M Halwani

Affiliations

R Alarfaj

King Saud University- King Abdullah International Medical Research Center; Corresponding author.

S Aljihani

Nanomedicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences

M Alzayer

Infectious Diseases Research Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences

S Al Johani

College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center

H Balkhy

World Health Organization (WHO)

A Yassin

Department of Pharmaceutical Sciences, Collage of pharmacy, King Saud bin Abdulaziz University for Health Sciences,King Abdullah International Medical Research Center

M Omer

Department of Pharmaceutical Sciences, Collage of pharmacy, King Saud bin Abdulaziz University for Health Sciences,King Abdullah International Medical Research Center

M AlKhulaifi

King Saud University- King Abdullah International Medical Research Center

M Alghoribi

Infectious Diseases Research Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences

M Halwani

Nanomedicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences